Last edition
News about "GLP-1 Therapy Vomiting Prevention"
Vanda Pharma's NEREUS Shows Positive Results in GLP-1 Vomiting Study
Vanda Pharmaceuticals has reported positive NEREUS Study 3601 results, showing reduced semaglutide-induced vomiting, including frequent, multi-day and extreme episodes.
GLP-1 Therapy Vomiting Prevention | 30/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members